...
首页> 外文期刊>Journal of Medical Case Reports >Adult cancer-related hemophagocytic lymphohistiocytosis – a challenging diagnosis: a case report
【24h】

Adult cancer-related hemophagocytic lymphohistiocytosis – a challenging diagnosis: a case report

机译:成人癌症相关的噬血细胞淋巴组织细胞增生症–一项具有挑战性的诊断:一例病例报告

获取原文
           

摘要

BackgroundAdult hemophagocytic lymphohistiocytosis is a secondary immunopathologic phenomenon, mainly secondary to malignancy, infection, or autoimmune disorders.The performance of diagnostic criteria, studied in the pediatric population, is yet to be validated in the adult population. Some of the criteria include cytopenias and organomegaly that are inherent features to malignant processes, thus making the diagnosis of hemophagocytic lymphohistiocytosis a challenge in patients with cancer. Case presentationWe describe the case of a 54-year-old white man with history of metastatic maxillary sinus adenoid cystic carcinoma who had severe liver injury and cytopenias with progressive clinical deterioration. We performed an evaluation, by flow cytometry, of the expression of surface markers in his natural killer cells that revealed remarkable abnormalities. His syndrome eventually fulfilled criteria for hemophagocytic lymphohistiocytosis and he received therapy with steroids with interval clinical improvement. Unfortunately, he refused further cytotoxic treatment and died 2 weeks later. ConclusionsThe conventional criteria for the diagnosis of hemophagocytic lymphohistiocytosis are suboptimal for adult patients with cancer resulting in delays in diagnosis and timely initiation of treatment. The diagnostic criteria have to be re-evaluated in patients with cancer; novel, easily available, and accurate diagnostic methods are needed.
机译:背景成人吞噬细胞淋巴组织细胞增生是继发性免疫病理现象,主要继发于恶性肿瘤,感染或自身免疫性疾病。在儿科人群中研究的诊断标准的性能尚未在成人人群中得到验证。其中一些标准包括血细胞减少和恶性肿大,这是恶性过程的固有特征,因此使吞噬性淋巴细胞组织细胞增生症的诊断成为癌症患者的一项挑战。病例介绍我们描述了一个54岁的白人病例,该病例具有转移性上颌窦腺样囊性癌的病史,患有严重的肝损伤和血细胞减少症,并伴有进行性临床恶化。我们通过流式细胞仪对他的自然杀伤细胞中表面标记的表达进行了评估,发现其异常异常。他的综合症最终达到了吞噬性淋巴细胞组织细胞增生的标准,并且他接受了类固醇的治疗,并获得了间歇性的临床改善。不幸的是,他拒绝进一步的细胞毒性治疗,并在2周后死亡。结论成年癌症患者诊断吞噬性淋巴细胞组织细胞增生症的常规标准不理想,导致诊断延迟和及时开始治疗。癌症患者的诊断标准必须重新评估;需要新颖,容易获得且准确的诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号